Acetylation site specificities of lysine deacetylase inhibitors in human cells (original) (raw)

• Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349–352 (1997).
  Article CAS Google Scholar
• Cheung, W.L., Briggs, S.D. & Allis, C.D. Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 12, 326–333 (2000).
  Article CAS Google Scholar
• Valenzuela-Fernández, A., Cabrero, J.R., Serrador, J.M. & Sanchez-Madrid, F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol. 18, 291–297 (2008).
  Article Google Scholar
• Yang, X.J. & Seto, E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31, 449–461 (2008).
  Article CAS Google Scholar
• Haberland, M., Montgomery, R.L. & Olson, E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32–42 (2009).
  Article CAS Google Scholar
• Finkel, T., Deng, C.X. & Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nature 460, 587–591 (2009).
  Article CAS Google Scholar
• Montgomery, R.L., Hsieh, J., Barbosa, A.C., Richardson, J.A. & Olson, E.N. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc. Natl. Acad. Sci. USA 106, 7876–7881 (2009).
  Article CAS Google Scholar
• Bolden, J.E., Peart, M.J. & Johnstone, R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5, 769–784 (2006).
  Article CAS Google Scholar
• Marks, P.A. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin. Investig. Drugs 19, 1049–1066 (2010).
  Article CAS Google Scholar
• Archin, N.M. et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487, 482–485 (2012).
  Article CAS Google Scholar
• Grabiec, A.M., Tak, P.P. & Reedquist, K.A. Function of histone deacetylase inhibitors in inflammation. Crit. Rev. Immunol. 31, 233–263 (2011).
  Article CAS Google Scholar
• Kazantsev, A.G. & Thompson, L.M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 7, 854–868 (2008).
  Article CAS Google Scholar
• Iyer, A., Fairlie, D.P. & Brown, L. Lysine acetylation in obesity, diabetes and metabolic disease. Immunol. Cell Biol. 90, 39–46 (2012).
  Article CAS Google Scholar
• Khan, O. & La Thangue, N.B. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol. Cell Biol. 90, 85–94 (2012).
  Article CAS Google Scholar
• Xu, W.S., Parmigiani, R.B. & Marks, P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26, 5541–5552 (2007).
  Article CAS Google Scholar
• Tan, J., Cang, S., Ma, Y., Petrillo, R.L. & Liu, D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J. Hematol. Oncol. 3, 5 (2010).
  Article Google Scholar
• Dell′Aversana, C., Lepore, I. & Altucci, L. HDAC modulation and cell death in the clinic. Exp. Cell Res. 318, 1229–1244 (2012).
  Article Google Scholar
• Bradner, J.E. et al. Chemical phylogenetics of histone deacetylases. Nat. Chem. Biol. 6, 238–243 (2010).
  Article CAS Google Scholar
• Bantscheff, M. et al. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255–265 (2011).
  Article CAS Google Scholar
• Salisbury, C.M. & Cravatt, B.F. Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc. Natl. Acad. Sci. USA 104, 1171–1176 (2007).
  Article CAS Google Scholar
• Ong, S.E. et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376–386 (2002).
  Article CAS Google Scholar
• Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834–840 (2009).
  Article CAS Google Scholar
• Weinert, B.T. et al. Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Reports 4, 842–851 (2013).
  Article CAS Google Scholar
• Sterner, D.E. & Berger, S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64, 435–459 (2000).
  Article CAS Google Scholar
• Drogaris, P. et al. Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation. Sci. Rep. 2, 220 (2012).
  Article Google Scholar
• Buggy, J.J. et al. CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo. Mol. Cancer Ther. 5, 1309–1317 (2006).
  Article CAS Google Scholar
• Haggarty, S.J., Koeller, K.M., Wong, J.C., Grozinger, C.M. & Schreiber, S.L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. USA 100, 4389–4394 (2003).
  Article CAS Google Scholar
• Balasubramanian, S. et al. A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas. Leukemia 22, 1026–1034 (2008).
  Article CAS Google Scholar
• Ben-Shahar, T.R. et al. Eco1-dependent cohesin acetylation during establishment of sister chromatid cohesion. Science 321, 563–566 (2008).
  Article CAS Google Scholar
• Unal, E. et al. A molecular determinant for the establishment of sister chromatid cohesion. Science 321, 566–569 (2008).
  Article Google Scholar
• Zhang, J. et al. Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast. Mol. Cell 31, 143–151 (2008).
  Article CAS Google Scholar
• Deardorff, M.A. et al. HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature 489, 313–317 (2012).
  Article CAS Google Scholar
• Bitterman, K.J., Anderson, R.M., Cohen, H.Y., Latorre-Esteves, M. & Sinclair, D.A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277, 45099–45107 (2002).
  Article CAS Google Scholar
• Chen, Y. et al. Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways. Mol. Cell. Proteomics 11, 1048–1062 (2012).
  Article CAS Google Scholar
• Kim, S.C. et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23, 607–618 (2006).
  Article CAS Google Scholar
• Zhao, S. et al. Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000–1004 (2010).
  Article CAS Google Scholar
• Zhang, X. et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 27, 197–213 (2007).
  Article CAS Google Scholar
• Uter, W. & Schnuch, A. EMA revokes marketing authorization for bufexamac. Contact Derm. 64, 235–236 (2011).
  Article Google Scholar
• Fukuda, H., Sato, Y., Usami, N., Yokouchi, Y. & Mukai, H. Contact dermatitis caused by bufexamac sparing the eruption of herpes zoster. J. Dermatol. 39, 405–407 (2012).
  Article Google Scholar
• Jeong, J.W. et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111, 709–720 (2002).
  Article CAS Google Scholar
• Dokmanovic, M., Clarke, C. & Marks, P.A. Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res. 5, 981–989 (2007).
  Article CAS Google Scholar
• Yang, H. et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095–1107 (2007).
  Article CAS Google Scholar
• Lain, S. et al. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 13, 454–463 (2008).
  Article CAS Google Scholar
• Anderson, K.A. & Hirschey, M.D. Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 52, 23–35 (2012).
  Article CAS Google Scholar
• Hirschey, M.D., Shimazu, T., Huang, J.Y., Schwer, B. & Verdin, E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb. Symp. Quant. Biol. 76, 267–277 (2011).
  Article CAS Google Scholar
• Wagner, G.R. & Payne, R.M. Mitochondrial acetylation and diseases of aging. J. Aging Res. 2011, 234875 (2011).
  Article Google Scholar
• He, W., Newman, J.C., Wang, M.Z., Ho, L. & Verdin, E. Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends Endocrinol. Metab. 23, 467–476 (2012).
  Article CAS Google Scholar
• Eltzschig, H.K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656–665 (2011).
  Article CAS Google Scholar
• Vizcaíno, J.A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223–226 (2014).
  Article Google Scholar
• Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011).
  Article Google Scholar
• Zhang, Y. et al. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol. Cell. Biol. 28, 1688–1701 (2008).
  Article CAS Google Scholar
• McBurney, M.W. et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23, 38–54 (2003).
  Article CAS Google Scholar
• Vaquero, A. et al. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256–1261 (2006).
  Article CAS Google Scholar
• Mostoslavsky, R. et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315–329 (2006).
  Article CAS Google Scholar
• Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896–1906 (2007).
  Article CAS Google Scholar
• Michalski, A. et al. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics 10, M111 011015 (2011).
  Article Google Scholar
• Kelstrup, C.D., Young, C., Lavallee, R., Nielsen, M.L. & Olsen, J.V. Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole orbitrap mass spectrometer. J. Proteome Res. 11, 3487–3497 (2012).
  Article CAS Google Scholar
• Waanders, L.F. et al. A novel chromatographic method allows on-line reanalysis of the proteome. Mol. Cell. Proteomics 7, 1452–1459 (2008).
  Article CAS Google Scholar
• Elias, J.E. & Gygi, S.P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207–214 (2007).
  Article CAS Google Scholar
• Emerling, B.M., Weinberg, F., Liu, J.L., Mak, T.W. & Chandel, N.S. PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc. Natl. Acad. Sci. USA 105, 2622–2627 (2008).
  Article CAS Google Scholar
• Weinert, B.T. et al. Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine. Cancer Immun. 9, 9 (2009).
  PubMed PubMed Central Google Scholar
• Szklarczyk, D. et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561–D568 (2011).
  Article CAS Google Scholar
• Cline, M.S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2, 2366–2382 (2007).
  Article CAS Google Scholar
• Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091–1093 (2009).
  Article CAS Google Scholar
• Garcia, O. et al. GOlorize: a Cytoscape plug-in for network visualization with Gene Ontology-based layout and coloring. Bioinformatics 23, 394–396 (2007).
  Article CAS Google Scholar